免疫瘤学回顾了本质:癌症的现代细胞和基因疗法
Neil Carleton1, Aaron B I Rosen2, Jishnu Das2
1University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, USA.
概括
免疫瘤学 (IO) 利用了一个世纪的研究,免疫检查点阻塞 (ICB) 推动了癌症治疗的近期成功. 下一代细胞和基因疗法建立在这种理解的基础上,以拦截癌症的发展.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 进化生物学 进化生物学
背景情况:
- 免疫瘤学 (IO) 已经发展了一个多世纪,起源于对炎症和瘤的洞察.
- 免疫检查点封锁 (ICB) 的成功使IO成为现代癌症治疗的基石.
- 已批准的细胞和基因疗法,包括CAR-T细胞和瘤病毒,代表了重大进展.
研究的目的:
- 审查免疫瘤学的历史发展和当前状况.
- 探索免疫系统学习和癌症进化能力的作用.
- 突出免疫系统与各种癌症之间的共同进化相互作用.
主要方法:
- 历史科学文献和临床试验数据的审查.
- 对分子生物学和免疫生物学原理的分析.
- 来自乳腺,结肠,前列腺,胰腺和肺癌的案例研究.
主要成果:
- IO已经从基本的观察到复杂的治疗策略.
- 了解免疫系统的可变性可以提高对癌症与免疫相互作用的洞察力.
- 下一代疗法正在出现,以更有效地针对癌症发展.
结论:
- 免疫瘤学是一个快速发展的领域,在基础科学上有很强的基础.
- 癌症和免疫系统的共同进化为新疗法提供了目标.
- 对细胞和基因疗法的持续研究有望改善对癌症的拦截.
相关概念视频
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...


